PDI, Inc. (PDII) will visit the NASDAQ MarketSite in New York City's Times Square. In honor of the occasion, Nancy Lurker, Chief Executive Officer of PDI, Inc. (PDII), will preside over the NASDAQ ...

PDI, Inc. (Nasdaq: PDII) today announced the signing of a collaboration agreement with a privately held molecular diagnostics company (the Company) to commercialize the Company's molecular diagnostic ...

SADDLE RIVER, N.J.--(BUSINESS WIRE)--PDI, Inc. (NASDAQ: PDII - News), a pioneer in providing contract sales and commercialization services to the biopharmaceutical industry, today announced that PDI ...

Welcome to the PDI second quarter financial results conference call. At this time, all participants are in a listen-only mode. Following management's prepared remarks, we will hold a Q&A session.

PDI provides commercialization services for established and emerging biopharmaceutical companies. The Company is dedicated to maximizing the return on investment for its clients by providing strategic ...

“With PD One, pharmaceutical marketers have a new tool that bridges the gap between the direct sales model and digital marketing, creating an entirely new communication channel to more effectively ...

PARSIPPANY, N.J., June 1, 2011 /PRNewswire/ -- PDI, Inc. (Nasdaq: PDII) today announced several new Contract Sales Organization (CSO) business wins that together are expected to generate total ...

"PDI will provide commercial leverage for capturing the value of our miRNA technology as it applies to thyroid and pancreatic cancer. We look forward to working with them through this transition as ...

NEW YORK--(BUSINESS WIRE)--Prolias Technologies, Inc. has filed suit against PDI Inc. (NASDAQ: PDII), a New Jersey-based company. PDI Inc. is alleged to have engaged breach of contract, breach of ...

Parsippany-based health care services company PDI, Inc., announced Tuesday that Graham G. Miao was named executive vice president and chief financial officer.When he starts in this role Monday, Oct.